Active ingredientCabozantinibCat. No. P-C004-001CAS 849217-68-1Family · Pharmaceutical analytical standards
Cabozantinib
An inhibitor of several tyrosine kinases involved in the growth of tumours and their blood vessels (including MET, VEGFR2 and RET), approved in the United States in 2012 for medullary thyroid cancer and later for kidney and liver cancer. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It comes in two versions, capsules and tablets, which are not interchangeable: they are formulated differently and were approved for different indications.
Go to the active ingredient →Active ingredientCabozantinibCat. No. P-C004-001CAS 849217-68-1
MetaboliteCabozantinib Metabolite 1Cat. No. P-C004-002CAS 1628530-37-9
MetaboliteCabozantinib Metabolite 2Cat. No. P-C004-003CAS 1628530-38-0
MetaboliteDesmethyl Cabozantinib GlucuronideCat. No. P-C004-004
MetaboliteDesquinolinyl Cabozantinib GlucuronideCat. No. P-C004-005CAS 1628530-43-7
Isotopically labelledCabozantinib-d4Cat. No. P-C004-007CAS 1802168-53-1
Isotopically labelledCabozantinib-d6Cat. No. P-C004-008CAS 1802168-46-2
ImpurityCabozantinib Impurity 1Cat. No. P-C004-009CAS 3697-66-3
Impurity1-(Phenylcarbamoyl)cyclopropanecarboxylic AcidCat. No. P-C004-010CAS 145591-80-6
ImpurityCabozantinib Impurity 2Cat. No. P-C004-011CAS 918642-61-2
ImpurityCabozantinib Impurity 3Cat. No. P-C004-012CAS 1275738-77-6
ImpurityCabozantinib Impurity 4Cat. No. P-C004-013CAS 849217-48-7
Impurity2-FluoroanilineCat. No. P-C004-014CAS 348-54-9
Impurity3,4-DimethoxyanilineCat. No. P-C004-015CAS 6315-89-5
ImpurityCabozantinib Impurity 5Cat. No. P-C004-016CAS 1355031-15-0
ImpurityCabozantinib Impurity 6Cat. No. P-C004-017CAS 190728-25-7
Impurity4-Chloro-6,7-dimethoxyquinolineCat. No. P-C004-018CAS 35654-56-9
Impurity4-Chloro-6,7-dimethoxyquinoline 1-oxideCat. No. P-C004-019CAS 2377278-36-7
ImpurityCabozantinib Impurity 7Cat. No. P-C004-020CAS 190728-24-6
Active ingredientCabozantinib (S)-MalateCat. No. P-C004-021CAS 1140909-48-3
ImpurityCabozantinib 2-Fluoro ImpurityCat. No. P-C004-022
ImpurityCabozantinib 3-Fluoro ImpurityCat. No. P-C004-023
ImpurityCabozantinib Carboxylic AcidCat. No. P-C004-024CAS 849217-77-2
ImpurityCabozantinib Dimer ImpurityCat. No. P-C004-025
ImpurityCabozantinib Impurity 8Cat. No. P-C004-026CAS 849221-94-9
ImpurityCabozantinib Impurity 9Cat. No. P-C004-027CAS 2439164-91-5
ImpurityCabozantinib Impurity 10Cat. No. P-C004-030
ImpurityCabozantinib Impurity 11Cat. No. P-C004-031CAS 1909050-22-1
ImpurityCabozantinib Impurity 12Cat. No. P-C004-032
ImpurityCabozantinib Impurity 13Cat. No. P-C004-033
ImpurityCabozantinib Impurity 14Cat. No. P-C004-034
ImpurityCabozantinib Impurity 15Cat. No. P-C004-035
ImpurityCabozantinib Impurity 16Cat. No. P-C004-036
ImpurityCabozantinib Impurity 17Cat. No. P-C004-037
ImpurityCabozantinib Impurity 18Cat. No. P-C004-038CAS 1905820-17-8
ImpurityCabozantinib Impurity 19Cat. No. P-C004-039
ImpurityCabozantinib Impurity 20Cat. No. P-C004-040CAS 2458244-61-4
ImpurityCabozantinib Impurity 21 HydrochlorideCat. No. P-C004-041
ImpurityCabozantinib Impurity 21 Sodium SaltCat. No. P-C004-042
ImpurityCabozantinib Impurity 22Cat. No. P-C004-043
ImpurityCabozantinib Malic acid Adduct ImpurityCat. No. P-C004-044
ImpurityCabozantinib N-OxideCat. No. P-C004-045CAS 1621681-63-7
ImpurityCabozantinib Quinol ImpurityCat. No. P-C004-046CAS 13425-93-9
ImpurityCabozantinib Urea DimerCat. No. P-C004-047CAS 2840522-81-6
Impurity7-O-Desmethyl CabozantinibCat. No. P-C004-048CAS 1628530-42-6
Impurity6-O-Desmethyl CabozantinibCat. No. P-C004-049CAS 1628530-47-1
ImpurityCabozantinib Impurity 23Cat. No. P-C004-050CAS 1345847-71-3
ImpurityCabozantinib Impurity 24Cat. No. P-C004-051CAS 1431468-36-8
ImpurityN,N'-Bis(4-fluorophenyl)oxamideCat. No. P-C004-052CAS 10197-51-0
ImpurityCabozantinib Impurity 25Cat. No. P-C004-053CAS 651054-52-3
ImpurityCabozantinib Impurity 26Cat. No. P-C004-054CAS 849217-60-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.